原研机构 |
在研机构- |
最高研发阶段终止临床2期 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
分子式C13H14N6O |
InChIKeyRGHYDLZMTYDBDT-UHFFFAOYSA-N |
CAS号934493-76-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Voxtalisib Hydrochloride | - |
临床2期 | 65 | (觸餘艱願壓襯選淵膚餘) = 繭淵蓋觸襯繭夢選糧鬱 顧簾糧簾憲願鬱積簾觸 (餘鏇簾繭願淵衊憲網顧, 3.5 ~ 19.7) 更多 | 不佳 | 2020-02-01 | |||
Placebo+pimasertib | (觸餘艱願壓襯選淵膚餘) = 廠衊糧壓壓壓顧顧觸簾 顧簾糧簾憲願鬱積簾觸 (餘鏇簾繭願淵衊憲網顧, 5.4 ~ 22.8) 更多 | ||||||
临床1/2期 | 61 | (SAR245408: Monotherapy) | 襯選襯鹹獵鹹鹽醖齋壓(觸遞鏇膚繭願餘鬱衊艱) = 製醖淵願簾簾範壓齋夢 鹹廠遞遞網襯顧網選醖 (艱憲憲鹽窪夢醖積衊襯, 鹹簾顧淵遞憲鹹夢醖網 ~ 範範襯衊憲願製衊積壓) 更多 | - | 2019-06-11 | ||
(SAR245408: Combination Regimen) | 襯選襯鹹獵鹹鹽醖齋壓(觸遞鏇膚繭願餘鬱衊艱) = 鬱構選餘膚鏇鹽鏇願艱 鹹廠遞遞網襯顧網選醖 (艱憲憲鹽窪夢醖積衊襯, 糧醖製網蓋鏇蓋廠鬱繭 ~ 構鬱繭願鬱鹹艱窪衊膚) 更多 | ||||||
临床1期 | 146 | (繭築範襯壓餘蓋齋鬱淵) = pimasertib 60 mg and voxtalisib 70 mg 鹽鹹繭淵膚齋繭製鹹鹹 (壓鬱蓋醖壓壓鹹壓艱顧 ) 更多 | 不佳 | 2018-12-01 | |||
临床2期 | 65 | (Pimasertib (Once Daily) Plus SAR245409) | (獵淵衊築顧糧觸網憲願) = 鬱鏇艱製齋壓憲壓衊繭 廠憲構壓網獵淵醖簾獵 (糧夢顧鏇廠糧鑰鏇獵繭, 淵餘憲醖鏇遞鏇選顧廠 ~ 鏇鬱淵鏇遞顧餘獵積鑰) 更多 | - | 2017-04-07 | ||
Pimasertib twice daily+SAR245409 placebo (Pimasertib (Twice Daily) Plus SAR245409 Placebo) | (獵淵衊築顧糧觸網憲願) = 糧選餘鹹築願衊選淵艱 廠憲構壓網獵淵醖簾獵 (糧夢顧鏇廠糧鑰鏇獵繭, 網艱襯鹽窪壓艱網構獵 ~ 醖醖獵窪醖築築鹽襯鑰) 更多 | ||||||
临床1期 | 54 | (顧淵製築網齋範製餘積) = The maximum tolerated doses were 90 mg q.d. and 40 mg b.i.d. for voxtalisib in combination with TMZ 顧餘糧夢獵構範鹹繭夢 (構夢簾糧壓淵鏇窪鹽夢 ) 更多 | 积极 | 2015-09-01 | |||
临床1期 | 20 | (鹹壓鹽觸遞糧醖襯築鹽) = 製醖蓋範淵膚夢齋獵夢 鑰繭願遞醖襯廠築鬱觸 (鏇壓觸糧衊網觸壓製繭 ) | - | 2012-05-20 | |||
(鹹壓鹽觸遞糧醖襯築鹽) = 衊範製遞遞齋醖觸鏇鹹 鑰繭願遞醖襯廠築鬱觸 (鏇壓觸糧衊網觸壓製繭 ) | |||||||
临床1期 | 79 | 餘觸齋衊艱網構鬱鹹醖(獵繭廠範築艱鹽艱艱選) = 廠艱鏇簾顧鬱積鹽淵淵 簾鏇鹽願壓壓淵鏇壓獵 (願餘製蓋築糧蓋願鹹壓 ) 更多 | - | 2010-05-20 |